OTCMKTS:MMEDF Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free MMEDF Stock Alerts $9.52 +0.09 (+0.95%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$9.21▼$9.6050-Day Range$4.77▼$11.7552-Week Range$0.29▼$5.07Volume653,571 shsAverage Volume3.38 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Mind Medicine (MindMed) alerts: Email Address Ad Stansberry ResearchThe Long-Awaited End of America UpdateA 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.Click here to find out for free. About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.Read More MMEDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MMEDF Stock News HeadlinesApril 24, 2024 | americanbankingnews.comMind Medicine (MindMed) (OTCMKTS:MMEDF) Trading 2.2% Higher April 17, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. (MNMD)May 2, 2024 | Stansberry Research (Ad)The Long-Awaited End of America UpdateA 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.March 27, 2024 | msn.comMind Medicine (NASDAQ:MNMD) is Leading the Surge in Psychedelic TherapiesMarch 22, 2024 | morningstar.comMind Medicine Inc Ordinary SharesMarch 17, 2024 | morningstar.comMind Medicine Inc Ordinary Shares MMEDFebruary 22, 2024 | benzinga.comMind Medicine Stock (NASDAQ:MNMD) Dividends: History, Yield and DatesDecember 20, 2023 | seekingalpha.comMMDCF Mind Medicine (MindMed) Inc. WT EXP 010724May 2, 2024 | Stansberry Research (Ad)The Long-Awaited End of America UpdateA 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.December 20, 2023 | msn.comWhat Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy StockDecember 12, 2023 | finance.yahoo.comMind Medicine (MindMed) Inc. (MMCWF)October 26, 2023 | financialpost.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business UpdateAugust 15, 2023 | benzinga.comMindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational YearAugust 4, 2023 | msn.comRBC Capital Maintains Mind Medicine (MNMD) Outperform RecommendationJuly 19, 2023 | stockhouse.comThinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?July 4, 2023 | thestreet.comMind Medicine (MindMed), Inc.June 27, 2023 | msn.comMindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path UpheldJune 22, 2023 | marketwatch.com8-K: Mind Medicine (MindMed) Inc.May 25, 2023 | businesswire.comMindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and ShareholdersMay 5, 2023 | benzinga.comFCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management's Track Record of Shareholder Value DestructionMay 1, 2023 | benzinga.comMindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business UpdateApril 26, 2023 | msn.comMindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital ManagementNovember 11, 2022 | benzinga.comMindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 TrialsOctober 26, 2022 | msn.comMind Medicine (MNMD) to Report Q3 Earnings: What's in Store?October 4, 2022 | nasdaq.comWhy Mind Medicine Stock Triumphed on TuesdaySeptember 29, 2022 | nasdaq.comWhy Mind Medicine Stock Soared on a Down Day for the MarketSeptember 29, 2022 | uk.investing.comMind Medicine Inc (MNMD)See More Headlines Receive MMEDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MMEDF CUSIPN/A CIKN/A Webwww.mindmed.co PhoneN/AFaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Jamon Alexander RahnCo-Founder, CEO & DirectorDr. Miriam Halperin WernliExec. Pres & DirectorDr. Scott M. Freeman (Age 64)Co-Founder & Clinical Advisor Mr. Leonard LatchmanCo-founderMr. David Dean GuebertChief Financial OfficerMs. Carol NastChief Operating OfficerMr. Bradford CrossChief Technology OfficerDr. Donald R. Gehlert Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardMs. Madeline FeldmanDirector of Operations & Admin.Mr. Collin GageVP of Corp. Devel.More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors MMEDF Stock Analysis - Frequently Asked Questions How have MMEDF shares performed in 2024? Mind Medicine (MindMed)'s stock was trading at $3.66 at the beginning of 2024. Since then, MMEDF shares have increased by 157.7% and is now trading at $9.43. View the best growth stocks for 2024 here. How do I buy shares of Mind Medicine (MindMed)? Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MMEDF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressYour bank is lying to you.MyBankTrackerTrump just won 2024Porter & CompanyA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
